Belldegrun A - Search Results

1

Positron emission tomography in urological oncology.

Hoh CK, Seltzer MA, Franklin J, deKernion JB, Phelps ME, Belldegrun A. Hoh CK, et al. Among authors: belldegrun a. J Urol. 1998 Feb;159(2):347-56. doi: 10.1016/s0022-5347(01)63916-8. J Urol. 1998. PMID: 9649238 Review.

2

Reevaluation of the 1997 TNM classification for renal cell carcinoma: T1 and T2 cutoff point at 4.5 rather than 7 cm. better correlates with clinical outcome.

Zisman A, Pantuck AJ, Chao D, Dorey F, Said JW, Gitlitz BJ, de Kernion JB, Figlin RA, Belldegrun AS. Zisman A, et al. Among authors: belldegrun as. J Urol. 2001 Jul;166(1):54-8. J Urol. 2001. PMID: 11435822

3

Surgery from a US perspective.

Dekernion JB, Franklin JR, Belldegrun A, Smith RB. Dekernion JB, et al. Among authors: belldegrun a. Cancer Surv. 1995;23:315-20. Cancer Surv. 1995. PMID: 7621471

4

Neoadjuvant hormonal deprivation in patients with locally advanced prostate cancer.

Macfarlane MT, Abi-Aad A, Stein A, Danella J, Belldegrun A, deKernion JB. Macfarlane MT, et al. Among authors: belldegrun a. J Urol. 1993 Jul;150(1):132-4. doi: 10.1016/s0022-5347(17)35414-9. J Urol. 1993. PMID: 7685421

5

Comparison of helical computerized tomography, positron emission tomography and monoclonal antibody scans for evaluation of lymph node metastases in patients with prostate specific antigen relapse after treatment for localized prostate cancer.

Seltzer MA, Barbaric Z, Belldegrun A, Naitoh J, Dorey F, Phelps ME, Gambhir SS, Hoh CK. Seltzer MA, et al. Among authors: belldegrun a. J Urol. 1999 Oct;162(4):1322-8. J Urol. 1999. PMID: 10492189 Clinical Trial.

6

Renal cell carcinoma: prognostic significance of incidentally detected tumors.

Tsui KH, Shvarts O, Smith RB, Figlin R, de Kernion JB, Belldegrun A. Tsui KH, et al. Among authors: belldegrun a. J Urol. 2000 Feb;163(2):426-30. doi: 10.1016/s0022-5347(05)67892-5. J Urol. 2000. PMID: 10647646

7

Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies.

Tsui KH, Shvarts O, Barbaric Z, Figlin R, de Kernion JB, Belldegrun A. Tsui KH, et al. Among authors: belldegrun a. J Urol. 2000 Feb;163(2):437-41. J Urol. 2000. PMID: 10647649

8

Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria.

Tsui KH, Shvarts O, Smith RB, Figlin RA, deKernion JB, Belldegrun A. Tsui KH, et al. Among authors: belldegrun a. J Urol. 2000 Apr;163(4):1090-5; quiz 1295. doi: 10.1016/s0022-5347(05)67699-9. J Urol. 2000. PMID: 10737472

9

Superficial bladder cancer: the role of interferon-alpha.

Belldegrun AS, Franklin JR, O'Donnell MA, Gomella LG, Klein E, Neri R, Nseyo UO, Ratliff TL, Williams RD. Belldegrun AS, et al. J Urol. 1998 Jun;159(6):1793-801. doi: 10.1016/S0022-5347(01)63160-4. J Urol. 1998. PMID: 9598463 Review.

10

CL1-GFP: an androgen independent metastatic tumor model for prostate cancer.

Patel BJ, Pantuck AJ, Zisman A, Tsui KH, Paik SH, Caliliw R, Sheriff S, Wu L, deKernion JB, Tso CL, Belldegrun AS. Patel BJ, et al. Among authors: belldegrun as. J Urol. 2000 Oct;164(4):1420-5. J Urol. 2000. PMID: 10992426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters